Samuel Bloor, PhD

Sam has a decade of experience in protein science and structural biology, applying biophysical and structural approaches to support drug discovery programmes. His expertise spans protein engineering, protein production, and structure-based characterisation of therapeutic targets. He is particularly interested in how advances in protein science can improve both the success and sustainability of drug discovery.

Before joining Sygnature Discovery, Sam completed his PhD at the University of Manchester, where he used directed evolution to develop novel enzymes for the synthesis of biofuels and pharmaceutical precursors.